BioCentury
ARTICLE | Financial News

Salmedix raises $45M

March 31, 2004 8:00 AM UTC

Cancer company Salmedix raised $45 million in a series C round led by HIG Ventures. Other investors included OrbiMed; Easton Hunt; Hunt Ventures; Novo A/S; Quilvest Capital; Clariden Bank; InterWest; Versant; Alexandria Equities; CMEA; Delphi; ProQuest; Ventures West; Aberdare Partners; GeneChem; and BioFrontier Global Investment Partnership. Aaron Davidson, managing director of HIG, and OrbiMed Principal Sam Wertheimer joined Salmedix's board. ...